Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saflutan in POAG or OHT with high IOP
NCT01979913Phase 4Completed
- Start
- Oct 2013
- Primary completion
- Apr 2014
- Countries
- 1
01
Overview
A Phase 4 trial of tafluprost in primary open-angle glaucoma (POAG), ocular hypertension. Started Oct 2013; status: completed.
02
Drugs
tafluprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01979913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01979913.